August 27, 2015

Forest Laboratories LLC et al v. Amneal Pharmaceuticals LLC et al

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. September 01, 2016

    Allergan OKs Generic Of Alzheimer's Drug Namzaric For 2025

    Amneal Pharmaceuticals LLC will be allowed to sell a generic version of Allergan PLC's Alzheimer's medication Namzaric in 2025 as part of a settlement announced Wednesday, likely ending litigation in Delaware federal court over the alleged infringement of a dozen patents.


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS